Advanced Cancer Therapy to Be Produced in UAE at 90% Lower Cost
Apr 20, 2025
In a major healthcare breakthrough, the UAE is set to manufacture CAR-T cell therapies locally, cutting treatment costs by up to 90% compared to international prices. The initiative, announced during Abu Dhabi Global Health Week, results from a partnership between Burjeel Holdings and US-based non-profit Caring Cross.
CAR-T therapy is a next-generation immunotherapy that reprograms a patient's immune cells to target and destroy cancer cells, primarily used to treat aggressive blood cancers like leukemia and lymphoma. With current global treatment prices ranging from USD 350,000 to over USD 1 million, access has remained limited across the MENA region.
This new initiative will establish a local manufacturing ecosystem, with Caring Cross supplying the technology, raw materials, and training needed to support point-of-care production. The first phase focuses on leukemia and lymphoma, with plans to expand into treatments for other diseases, including HIV.
The partnership aims to position the UAE as a regional hub for advanced cell and gene therapies, enhancing access to life-saving treatments and supporting healthcare sustainability across underserved populations in MENA and beyond.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
See - Sada Elbalad
a day ago
- See - Sada Elbalad
Tunisian Startup Revolutionizes Prosthetics with AI-Powered Bionic Limbs
Israa Farhan A Tunisian medtech startup based in the coastal city of Sousse is transforming the future of prosthetics by developing lightweight, AI-powered bionic arms that combine cutting-edge engineering with affordability. Founded in early 2020 by engineer Mohamed Dhaouafi, Cure Bionics produces 3D-printed prosthetic limbs controlled by muscle signals through advanced electromyography (EMG) sensors. The company's mission is to make high-quality prosthetics accessible, particularly for children, at a fraction of the cost of imported alternatives. Dhaouafi said the idea was born during his studies at the National Engineering School of Sousse, when a student competition led to a life-changing project. A teammate's relative was born with a congenital limb difference but could not afford a prosthetic until she was 20, and even then, the options were prohibitively expensive or unavailable locally. This inspired the team to design affordable, high-performance bionic limbs and rehabilitation solutions. Unlike traditional prosthetics, which can cost up to 50,000 US dollars and take months to manufacture, Cure Bionics' arm prostheses are ready within a week and priced around 8,000 US dollars. Intensive care medicine professor Amine Allah Massadi from the University of Tunis notes that these bionic limbs deliver advanced technical performance at 50% or more below the cost of comparable foreign products. Inside the company's lab, engineers scan patient limbs using the Myo Finder device, which reads EMG signals in real time. Users, like Yassine Jarsa, train via the Myo Link mobile app, which simulates bionic hand control in 2D before fitting the actual device. The company's flagship prosthetic arm, named Hannibal, offers a suite of features tailored to amputees' needs. It includes a rotating wrist joint, an adjustable socket, magnetic charging to eliminate battery removal, and tactile feedback for partial sensation restoration. With a simple mode-switch button, users can alternate between assistive and automatic functions, lock movement, and even feel vibrations that simulate touch. read more UAE's Lunar Mission Delayed to Tomorrow Twitter Lifts Trump's Account Ban Scientists Find Evidence Of 10،000 Black Holes Surrounding The Center Of The Milky Way Galaxy Greenhouse In Antarctica Able To Grow Vegetables Without Soil Or Sunlight Moving Over China: U.S. Is Again Home to World's Speediest Supercomputer Technology The 10 most expensive cars in the world Technology Top 10 fastest cars in the world Technology Lasers Could Make Computers 1 Million Times Faster Technology Smart technology taking control of our lives Videos & Features Story behind Trending Jessica Radcliffe Death Video News Israeli-Linked Hadassah Clinic in Moscow Treats Wounded Iranian IRGC Fighters Arts & Culture "Jurassic World Rebirth" Gets Streaming Date News China Launches Largest Ever Aircraft Carrier News Ayat Khaddoura's Final Video Captures Bombardment of Beit Lahia Business Egyptian Pound Undervalued by 30%, Says Goldman Sachs Videos & Features Tragedy Overshadows MC Alger Championship Celebration: One Fan Dead, 11 Injured After Stadium Fall Arts & Culture South Korean Actress Kang Seo-ha Dies at 31 after Cancer Battle Lifestyle Get to Know 2025 Eid Al Adha Prayer Times in Egypt Arts & Culture Lebanese Media: Fayrouz Collapses after Death of Ziad Rahbani
Al-Ahram Weekly
4 days ago
- Al-Ahram Weekly
Six aid seekers among 10 Palestinians killed by Israeli troops in Gaza Saturday - War on Gaza
Gaza's civil defence agency said at least 10 people were killed across the Palestinian territory on Saturday, including civilians who were waiting to collect aid. Civil defence spokesman Mahmoud Bassal told AFP that at least six people were killed and 30 wounded after Israeli troops targeted civilians assembling near an aid point in central Gaza. Israeli strikes also hit areas in central Gaza, resulting in multiple casualties. Thousands of Gazans congregate daily near food distribution points in Gaza, including four managed by the US- and Israeli-backed so-called Gaza Humanitarian Foundation. Since launching in late May, its operations have been marred by almost-daily reports of Israeli forces killing those waiting to collect food and aid supplies. Israeli restrictions on the entry of supplies into Gaza since the start of the genocidal war nearly two years ago have led to shortages of food and essential supplies, including medicine and fuel, which hospitals require to power their generators. An Israeli blockade imposed since 2 March has further worsened conditions in the war-torn Strip, prompting warnings of widespread famine. Early Friday, Israel's security cabinet approved plans to take control of Gaza City, sparking a wave of international outrage. Despite the backlash and rumours of dissent from Israeli military top brass, Prime Minister Benjamin Netanyahu remained defiant over the decision. In a post on social media late Friday, Netanyahu said, "We are not going to occupy Gaza -- we are going to free Gaza from Hamas". Netanyahu faces increasing domestic pressure to secure a ceasefire in Gaza to facilitate the release of captives held by Palestinian militants, while internationally, criticism grows as more than two million Palestinians endure famine under Israel's five-month blockade of the Strip. Hamas slammed the Israeli plan to occupy Gaza City, calling it a "new war crime". Israel's 22-month war on Gaza has killed more than 61,300 Palestinians -- mostly women and children -- and wounded over 152,000, according to Gaza's Health Ministry. Independent estimates suggest the actual death toll may be significantly higher. * This story was edited by Ahram Online Follow us on: Facebook Instagram Whatsapp Short link:
Daily News Egypt
7 days ago
- Daily News Egypt
Egypt signs vaccine production agreement with UAE's Al Qalaa, China's Red Flag
Egypt's Holding Company for Biological Products and Vaccines (VACSERA) has signed a memorandum of understanding (MoU) with UAE-based Al Qalaa Investments and China's Red Flag to expand its capacity in human and veterinary vaccine production and develop plasma-derived therapies, the Ministry of Health announced on Monday. Health Ministry spokesperson Hossam Abdel Ghaffar said the agreement supports Egypt's national strategy to attract foreign investment, localise biotechnology industries, and advance scientific research and innovation under the country's Vision 2030 sustainable development framework. The partnership aims to position Egypt as a regional hub for vaccine manufacturing and exports—particularly to African and Arab markets—while ensuring self-sufficiency in critical vaccines and plasma-based products. Sherif El-Fil, CEO of VACSERA, described the deal as a major step toward transferring advanced vaccine manufacturing technologies to Egypt. He said it would secure the domestic supply of safe, effective vaccines and open new export opportunities. El-Fil added that the collaboration will also strengthen VACSERA's capabilities in plasma processing and biopharmaceutical production, reinforcing its role as a key regional player in the vaccine industry. The MoU was signed by Sherif El-Fil for VACSERA, Li Yang, CEO of China's Red Flag, and Ashraf El-Badawy, CEO of UAE's Al Qalaa Investments.
